JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Montfrans, C.
Right arrow Articles by te Velde, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Montfrans, C.
Right arrow Articles by te Velde, A. A.

In Vivo Evaluation of 111In-Labeled T-Lymphocyte Homing in Experimental Colitis

Catherine van Montfrans, MD, PhD1, Roelof J. Bennink, MD, PhD2, Kora de Bruin2, Wouter de Jonge, PhD3, Hein J. Verberne, MD2, Fiebo J.W. ten Kate, MD, PhD4, Sander J.H. van Deventer, MD, PhD3 and Anje A. te Velde, PhD1

1 Department of Experimental Internal Medicine, Academic Medical Center, Amsterdam, The Netherlands
2 Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands
3 Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands
4 Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands



View larger version (12K):

[in a new window]
 
FIGURE 1. Colon radioactivity uptake is increased in mice with TNBS colitis transferred with TNBS-sensitized 111In-labeled lymphocytes. SPECT was performed 48 h after transfer of 111In-labeled TNBS-sensitized or nonsensitized lymphocytes to TNBS and saline control mice. Colon uptake was calculated normalized to bone marrow uptake in pelvis and corrected for background activity: (colon – background)/(bone marrow – background). Box plots of mean radioactivity uptake in 4 groups are shown (donor–acceptor). Overall comparison, P = 0.002; individual comparison between TNBS–TNBS group and 3 other groups, **P = 0.004 (statistically significant).

 


View larger version (145K):

[in a new window]
 
FIGURE 2. Increased radioactivity on SPECT of mice with TNBS colitis mice transferred with TNBS-sensitized 111In-labeled lymphocytes. SPECT was performed 48 h after transfer of 111In-labeled TNBS-sensitized or nonsensitized lymphocytes to TNBS and saline control mice. Transverse slices from abdominal region at pelvic level are shown; amount of 111In uptake is color coded from low (black) to high (white). Four images are representative of 4 groups (donor–acceptor). (A) Colon uptake is low in NaCl–NaCl mouse. (B) Colon uptake is equivocal in TNBS–NaCl mouse. (C) Colon uptake is equivocal in NaCl–TNBS mouse. (D) Colon uptake (arrow) is manifest in TNBS–TNBS mouse.

 


View larger version (31K):

[in a new window]
 
FIGURE 3. TNBS-sensitized lymphocytes exacerbate colitis. TNBS or saline control mice were transferred with TNBS-sensitized or nonsensitized 111In-labeled lymphocytes as indicated (donor–acceptor). Weight of the last 6 cm of colon was determined on sacrifice after SPECT. TNBS–TNBS mice had significantly higher colon weights than weights of mice in other 3 groups. Data represent mean ± SEM. Overall comparison, P = 0.0015; individual comparison between TNBS–TNBS group and 3 other groups, **P < 0.05 (statistically significant).

 


View larger version (139K):

[in a new window]
 
FIGURE 4. TNBS-sensitized lymphocytes exacerbate colitis. Extent of mucosal inflammation was graded and mean total histologic scores per group (donor–acceptor) are shown. (A and B) NaCl–NaCl mouse (A) and TNBS–NaCl mouse (B) with normal colon architecture and small number of leukocytes in mucosa. (C) NaCl–TNBS mouse with inflammation (significantly less severe than in D), consisting of edema and influx of inflammatory cells, but no ulcerations and fibrosis. (D) TNBS–TNBS mouse with severe colitis characterized by edema, extensive influx of inflammatory cells, ulcerations, crypt loss, and fibrosis. (Hematoxylin–eosin, x33)

 


View larger version (11K):

[in a new window]
 
FIGURE 5. Colon uptake ratio correlated with parameters of colitis. Mice with TNBS colitis were transferred with TNBS-sensitized or nonsensitized 111In-labeled lymphocytes. Each symbol represents 1 mouse. (A) Significant correlation between histology (x-axis) and CUR (y-axis) (P < 0.001). Correlation coefficient R2 = 0.933. (B) Significant correlation between colon weight (x-axis) and CUR (y-axis) (P < 0.001). Correlation coefficient R2 = 0.836.

 


View larger version (9K):

[in a new window]
 
FIGURE 6. Colon radioactivity uptake is decreased after anti-{alpha}4 antibody injection. SPECT was performed on mice with TNBS colitis 48 h after transfer of 111In-labeled TNBS-sensitized lymphocytes and injection of control antibody or anti-{alpha}4 antibody. (A) CUR was calculated normalized to bone marrow uptake in pelvis. Box plots of mean radioactivity uptake of 2 groups are indicated (*P = 0.012 [statistically significant]). (B) Isolated colons were also counted in {gamma}-counter; {gamma}-counter results were corrected for decay and expressed as cpm/g tissue. To correct for nonspecific binding, ratios were calculated normalized to radioactivity in blood: (cpm/g colon – cpm/g blood)/(cpm/g blood) (*P = 0.05 [statistically significant]).

 


View larger version (88K):

[in a new window]
 
FIGURE 7. Blockade of CD4+ cell migration to colon after anti-{alpha}4 antibody injection. Ex vivo planar scintigraphic images of isolated cleaned colon show distinct colon radioactivity uptake in mouse with TNBS colitis transferred with sensitized 111In-labeled CD4+ lymphocytes (A). Colon radioactivity uptake is decreased after treatment with anti-{alpha}4 antibody (B). Images are representative of 5 mice per group.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.